Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gail Hecht

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Gut Microbes|June 4, 2011
Determination of spatial and temporal colonization of enteropathogenic E. coli and enterohemorrhagic E. coli in mice using bioluminescent in vivo imagingKi-Jong Rhee, Hao Cheng, Antoneicka Harris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2018
Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660-A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile InfectionErik R Dubberke, Christine H Lee, Robert Orenstein, et al.
Infection and Immunity|May 25, 2004
Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier functionV K Viswanathan, Athanasia Koutsouris, Sandra Lukic, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 3, 2005
Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cellsRachna Sharma, Samuel Tesfay, Farol L Tomson, et al.
Gastroenterology|September 14, 2004
Differing roles of protein kinase C-zeta in disruption of tight junction barrier by enteropathogenic and enterohemorrhagic Escherichia coliFarol L Tomson, Athanasia Koutsouris, V K Viswanathan, et al.
Infection and Immunity|April 16, 2002
A gene from the locus of enterocyte effacement that is required for enteropathogenic Escherichia coli to increase tight-junction permeability encodes a chaperone for EspFSimon J Elliott, Colin B O'Connell, Athanasia Koutsouris, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 13, 2004
Differential regulation of Na+/H+ exchange isoform activities by enteropathogenic E. coli in human intestinal epithelial cellsGail Hecht, Kim Hodges, Ravinder K Gill, et al.
Gastroenterology|July 10, 2002
A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal diseaseYevgeny Zolotarevsky, Gail Hecht, Athanasia Koutsouris, et al.
Gastroenterology|April 6, 2007
Does gender affect career satisfaction and advancement in gastroenterology? Results of an AGA institute-sponsored surveyLauren B Gerson, Kay Twomey, Gail Hecht, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 19, 2010
Enterohemorrhagic E. coli alters murine intestinal epithelial tight junction protein expression and barrier function in a Shiga toxin independent mannerJennifer L Roxas, Athanasia Koutsouris, Amy Bellmeyer, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Gut Microbes|June 4, 2011
Determination of spatial and temporal colonization of enteropathogenic E. coli and enterohemorrhagic E. coli in mice using bioluminescent in vivo imagingKi-Jong Rhee, Hao Cheng, Antoneicka Harris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2018
Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660-A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile InfectionErik R Dubberke, Christine H Lee, Robert Orenstein, et al.
Infection and Immunity|May 25, 2004
Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier functionV K Viswanathan, Athanasia Koutsouris, Sandra Lukic, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 3, 2005
Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cellsRachna Sharma, Samuel Tesfay, Farol L Tomson, et al.
Gastroenterology|September 14, 2004
Differing roles of protein kinase C-zeta in disruption of tight junction barrier by enteropathogenic and enterohemorrhagic Escherichia coliFarol L Tomson, Athanasia Koutsouris, V K Viswanathan, et al.
Infection and Immunity|April 16, 2002
A gene from the locus of enterocyte effacement that is required for enteropathogenic Escherichia coli to increase tight-junction permeability encodes a chaperone for EspFSimon J Elliott, Colin B O'Connell, Athanasia Koutsouris, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 13, 2004
Differential regulation of Na+/H+ exchange isoform activities by enteropathogenic E. coli in human intestinal epithelial cellsGail Hecht, Kim Hodges, Ravinder K Gill, et al.
Gastroenterology|July 10, 2002
A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal diseaseYevgeny Zolotarevsky, Gail Hecht, Athanasia Koutsouris, et al.
Gastroenterology|April 6, 2007
Does gender affect career satisfaction and advancement in gastroenterology? Results of an AGA institute-sponsored surveyLauren B Gerson, Kay Twomey, Gail Hecht, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 19, 2010
Enterohemorrhagic E. coli alters murine intestinal epithelial tight junction protein expression and barrier function in a Shiga toxin independent mannerJennifer L Roxas, Athanasia Koutsouris, Amy Bellmeyer, et al.
Pageof 4